Peter Canoll

9PUBLICATIONS
40CO-AUTHORS
Haematological tumoursBiologically active moleculesMicrobial geneticsMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.

|Mar 05, 2025
A high-throughput anaerobic method for viability assays.

Mohamed El-Fateh, Christian T Meyer, Anushree Chatterjee

|Aug 21, 2024
Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies.

Christian T Meyer, Brianna N Smith, Jing Wang

|Jun 19, 2024
Resistance to Spindle Inhibitors in Glioblastoma Depends on STAT3 and Therapy Induced Senescence.

Natanael Zarco, Athanassios Dovas, Virginea de Araujo Farias

|May 15, 2024
MT-125 Inhibits Non-Muscle Myosin IIA and IIB, Synergizes with Oncogenic Kinase Inhibitors, and Prolongs Survival in Glioblastoma.

Rajappa Kenchappa, Laszlo Radnai, Erica J Young

Pageof 2